Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin for psychogenic jerks
NL-OMON28532Phase 2Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Functional Motor Disorder (FMD) comparing Botulinum neurotoxin with Placebo (2 arms). Primary endpoint: Improvement in jerk severity. Planned start Feb 2011; status: not yet recruiting.
02
Drugs
botulinum neurotoxin
03
Conditions
Functional Motor Disorder (FMD)
Beyond the preview
Go deeper on NL-OMON28532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28532.